Home Healthcare Pharmaceuticals Anti-Inflammatory Therapeutics Market

Anti-Inflammatory Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids), By Indication (Arthritis, Anti-inflammatory Bowel Disease (IBD), Respiratory Disease, Multiple Sclerosis, Psoriasis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Providers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR3297DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Anti-Inflammatory Therapeutics Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Anti-inflammatory Biologics
    2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    3. Corticosteroids
  2. Anti-Inflammatory Therapeutics Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Arthritis
    2. Anti-inflammatory Bowel Disease (IBD)
    3. Respiratory Disease
    4. Multiple Sclerosis
    5. Psoriasis
    6. Others
  3. Anti-Inflammatory Therapeutics Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Providers
  4. Regional Anti-Inflammatory Therapeutics Market
    1. North America
      1. North America Anti-Inflammatory Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
      2. North America Anti-Inflammatory Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Arthritis
        2. Anti-inflammatory Bowel Disease (IBD)
        3. Respiratory Disease
        4. Multiple Sclerosis
        5. Psoriasis
        6. Others
      3. North America Anti-Inflammatory Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Providers
      4. U.S.
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      5. Canada
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
    2. Europe
      1. Europe Anti-Inflammatory Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
      2. Europe Anti-Inflammatory Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Arthritis
        2. Anti-inflammatory Bowel Disease (IBD)
        3. Respiratory Disease
        4. Multiple Sclerosis
        5. Psoriasis
        6. Others
      3. Europe Anti-Inflammatory Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Providers
      4. U.K.
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      5. Germany
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      6. France
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      7. Spain
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      8. Italy
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      9. Russia
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      10. Nordic
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      11. Benelux
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      12. Rest of Europe
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
    3. APAC
      1. APAC Anti-Inflammatory Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
      2. APAC Anti-Inflammatory Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Arthritis
        2. Anti-inflammatory Bowel Disease (IBD)
        3. Respiratory Disease
        4. Multiple Sclerosis
        5. Psoriasis
        6. Others
      3. APAC Anti-Inflammatory Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Providers
      4. China
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      5. Korea
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      6. Japan
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      7. India
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      8. Australia
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      9. Taiwan
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      10. South East Asia
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      11. Rest of Asia-Pacific
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
    4. Middle East and Africa
      1. Middle East and Africa Anti-Inflammatory Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
      2. Middle East and Africa Anti-Inflammatory Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Arthritis
        2. Anti-inflammatory Bowel Disease (IBD)
        3. Respiratory Disease
        4. Multiple Sclerosis
        5. Psoriasis
        6. Others
      3. Middle East and Africa Anti-Inflammatory Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Providers
      4. UAE
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      5. Turkey
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      6. Saudi Arabia
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      7. South Africa
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      8. Egypt
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      9. Nigeria
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      10. Rest of MEA
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
    5. LATAM
      1. LATAM Anti-Inflammatory Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
      2. LATAM Anti-Inflammatory Therapeutics Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Arthritis
        2. Anti-inflammatory Bowel Disease (IBD)
        3. Respiratory Disease
        4. Multiple Sclerosis
        5. Psoriasis
        6. Others
      3. LATAM Anti-Inflammatory Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Providers
      4. Brazil
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      5. Mexico
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      6. Argentina
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      7. Chile
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      8. Colombia
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
      9. Rest of LATAM
        1. Anti-inflammatory Biologics
        2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
        3. Corticosteroids
        4. Arthritis
        5. Anti-inflammatory Bowel Disease (IBD)
        6. Respiratory Disease
        7. Multiple Sclerosis
        8. Psoriasis
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Providers
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.